Seattle, WA — December 22, 2025 - Blink Anesthesia Accelerates Growth With 119-System Rollout at Leading Maryland Academic Hospital
Blink Anesthesia announced today that one of the leading academic medical centers in the U.S. has begun installing 119 TwitchView® Train-of-Four (TOF) Monitoring Systems, marking an important advancement in patient safety and anesthesia care.
By deploying TwitchView® TOF Monitors across its surgical departments, the Maryland academic institution aims to improve consistency in neuromuscular blockade management, support compliance with ASA guidelines, and reduce costs associated with preventable postoperative complications and avoidable drug spend.
This is one of Blink Anesthesia’s largest installations to date within a single medical center and marks a significant milestone in its mission to eliminate residual neuromuscular blockade. The deployment underscores the increasing trend toward system-wide adoption of quantitative neuromuscular monitoring and reinforces the emergence of newer, clinically validated, EMG-based monitors like TwitchView as the new standard of care.
“We are honored to partner with such a respected academic medical center on an adoption of this scale. This is what we do best—partner with hospitals to implement system-wide quantitative monitoring so that we can make the anesthetist’s job easier— and their patients safer.” said Justin Hulvershorn, MD, PhD, CEO of Blink Anesthesia.
Blink Anesthesia continues to expand its footprint across academic, community, and integrated health systems, and anticipates further large-scale deployments in early 2026 and beyond.
About Blink Anesthesia:
Blink Anesthesia is a Seattle-based medical device company dedicated to improving patient safety in anesthesia practice. We develop breakthrough anesthesia technology that is designed to improve patient safety. Our flagship product, the TwitchView® Train of Four Monitor, is a quantitative neuromuscular monitor that helps anesthetists eliminate residual paralysis and allows hospitals to align with the 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade.
Media Contact:
Leslie Aberman
Strategic Counsel and Business Affairs
leslie.aberman@blinkdc.com
Blink Device Company, LLC
